Bone Marrow TransplantationTransplantation, HomologousBlood DonorsGraft vs Host DiseaseStem CellsBone MarrowHematopoietic Stem Cell TransplantationTransplantation, AutologousExchange Transfusion, Whole BloodBone Marrow CellsPeripheral Blood Stem Cell TransplantationWhole-Body IrradiationTransplantation ConditioningHematopoietic Stem CellsLeukemiaTissue DonorsBlood TransfusionAnemia, AplasticTransplantation ChimeraBusulfanGraft SurvivalLeukemia, Myelogenous, Chronic, BCR-ABL PositiveStem Cell TransplantationHistocompatibility TestingHematologic NeoplasmsRecurrenceHistocompatibilityLeukocyte TransfusionCyclophosphamideGraft vs Tumor EffectFetal BloodHematopoietic Stem Cell MobilizationRemission InductionLeukemia, Myeloid, AcuteCombined Modality TherapyPrecursor Cell Lymphoblastic Leukemia-LymphomaLymphocyte DepletionRadiation ChimeraGraft vs Leukemia EffectHematopoiesisGranulocyte Colony-Stimulating FactorABO Blood-Group SystemTransplantation, IsogeneicGraft vs Host ReactionTreatment OutcomeAcute DiseaseMice, Inbred C57BLImmunosuppressive AgentsAntigens, CD34Bone Marrow PurgingTime FactorsLymphocyte TransfusionHepatic Veno-Occlusive DiseaseLeukemia, MyeloidBone and BonesChimeraT-LymphocytesEmbryonic Stem CellsCord Blood Stem Cell TransplantationCell DifferentiationMyelodysplastic SyndromesImmunosuppressionNuclear FamilyAdult Stem CellsCyclosporineTransplantation ImmunologySurvival AnalysisRetrospective StudiesLymphoma, Non-HodgkinHLA AntigensCytomegalovirus InfectionsLiver TransplantationHematologic DiseasesAntineoplastic Combined Chemotherapy ProtocolsGraft RejectionLeukapheresisFatal OutcomeCytarabineFlow CytometryMultiple MyelomaCells, CulturedColony-Forming Units AssayActuarial AnalysisPluripotent Stem CellsSurvival RateDisease-Free SurvivalBone Marrow DiseasesMice, Inbred BALB CEtoposideMelphalanInfectionCell SeparationFollow-Up StudiesMesenchymal Stem Cell TransplantationStem Cell NicheSevere Combined ImmunodeficiencyLeukocyte CountImmunophenotypingCell LineageBlood Cells